Dr. Amie Elissa Jackson, MD

Dr. Jackson practices at Baptist Health Lexington in Lexington, Kentucky, part of Baptist Health.

Dr. Jackson's NPI, 1023246949, was assigned on June 30, 2009. Dr. Jackson graduated from University of Kentucky College of Medicine in 2009. Dr. Jackson holds Kentucky license 56752.

Dr. Jackson's primary practice is Baptist Health Lexington, at 1740 Nicholasville Road, Lexington, KY 40503 in Fayette County. The practice phone is (859) 260-6100.

Dr. Jackson's primary practice is Baptist Health Lexington in Lexington, Kentucky, part of Baptist Health. Dr. Jackson is also affiliated with Baptist Health Corbin. The medical group on file is Baptist Health Medical Group. Dmand AI also links Dr. Jackson to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jackson practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Jackson's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Jackson is board certified in hematology by the American Board of Internal Medicine. Dr. Jackson is licensed in Kentucky.

CMS data shows 875 Medicare services from Dr. Jackson across 9 procedure codes in 2024, for 240 Medicare patients. Medicare paid $82,671 for them.

CMS counts 240 Medicare patients who saw Dr. Jackson in 2024. The largest group is 65 to 74, with 119 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jackson's median patient age at 67, with 77% women.

In 2024, Dr. Jackson wrote 1,609 Medicare Part D claims for 243 patients. 88% of them were for generic drugs. CMS names the drug for 1,315 of them, across 40 drugs with 11 or more claims each, at $1,008,777 in total drug cost. In 2023, CMS named 915 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Jackson for performance year 2024, reported through an alternative payment model (APM). Dr. Jackson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jackson as offering telehealth.

Dmand AI links 7 papers to Dr. Jackson, published from 2014 to 2024. 2014 was the busiest year, with 2. The most frequent topics are Hematopoietic Stem Cell Transplantation. Dr. Jackson has published most often in Am J Hematol. Dr. Jackson's most frequent co-authors are Grzegorz S. Nowakowski, MD, Thomas E. Witzig, MD and Brian Leslie Burnette, MD.

Dmand AI links Dr. Jackson to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 30 general payments to Dr. Jackson from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 63% of the total. AstraZeneca Pharmaceuticals LP paid the most, $408.

Dr. Jackson graduated from University of Kentucky College of Medicine in 2009.